1. Home
  2. LEGN vs VNT Comparison

LEGN vs VNT Comparison

Compare LEGN & VNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • VNT
  • Stock Information
  • Founded
  • LEGN 2014
  • VNT 2019
  • Country
  • LEGN United States
  • VNT United States
  • Employees
  • LEGN N/A
  • VNT N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • VNT Industrial Machinery/Components
  • Sector
  • LEGN Health Care
  • VNT Industrials
  • Exchange
  • LEGN Nasdaq
  • VNT Nasdaq
  • Market Cap
  • LEGN 5.4B
  • VNT 5.4B
  • IPO Year
  • LEGN 2020
  • VNT N/A
  • Fundamental
  • Price
  • LEGN $35.56
  • VNT $43.71
  • Analyst Decision
  • LEGN Strong Buy
  • VNT Strong Buy
  • Analyst Count
  • LEGN 10
  • VNT 8
  • Target Price
  • LEGN $73.67
  • VNT $47.43
  • AVG Volume (30 Days)
  • LEGN 1.1M
  • VNT 1.2M
  • Earning Date
  • LEGN 08-11-2025
  • VNT 07-31-2025
  • Dividend Yield
  • LEGN N/A
  • VNT 0.24%
  • EPS Growth
  • LEGN N/A
  • VNT 1.28
  • EPS
  • LEGN N/A
  • VNT 2.63
  • Revenue
  • LEGN $796,838,000.00
  • VNT $3,041,400,000.00
  • Revenue This Year
  • LEGN $66.76
  • VNT $2.32
  • Revenue Next Year
  • LEGN $52.58
  • VNT $4.92
  • P/E Ratio
  • LEGN N/A
  • VNT $16.06
  • Revenue Growth
  • LEGN 74.75
  • VNT 1.16
  • 52 Week Low
  • LEGN $27.34
  • VNT $27.22
  • 52 Week High
  • LEGN $59.62
  • VNT $43.74
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 35.54
  • VNT 67.99
  • Support Level
  • LEGN $35.10
  • VNT $41.98
  • Resistance Level
  • LEGN $38.35
  • VNT $43.09
  • Average True Range (ATR)
  • LEGN 1.31
  • VNT 0.90
  • MACD
  • LEGN -0.37
  • VNT 0.05
  • Stochastic Oscillator
  • LEGN 11.33
  • VNT 98.58

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About VNT Vontier Corporation

Vontier, spun off from Fortive in 2020, is an industrial technology company with a portfolio of transportation and mobility solutions. The company offers a wide array of products and services, including fueling equipment, sensors, point-of-sale and payment systems, telematics, and equipment used by vehicle mechanics and technicians. Vontier generated approximately $3 billion in sales in 2024.

Share on Social Networks: